TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Alligator Bioscience AB
Closing information (x1000 SEK)
Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Turnover |
58,107
|
35,696
|
12,943 |
Financial expenses |
1,487
|
646
|
233 |
Earnings before taxes |
-248,586
|
-193,403
|
-141,736 |
EBITDA |
-238,494
|
-181,022
|
-130,421 |
Total assets |
118,450
|
169,584
|
333,200 |
Current assets |
78,188
|
122,814
|
299,613 |
Current liabilities |
99,079
|
64,529
|
47,416 |
Equity capital |
11,855
|
89,052
|
282,273 |
- share capital |
42,170
|
88,614
|
88,234 |
Employees (average) |
56
|
50
|
45 |
Financial ratios
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Solvency |
10.0%
|
52.5%
|
84.7% |
Turnover per employee |
1,038
|
714
|
288 |
Profit as a percentage of turnover |
-427.8%
|
-541.8%
|
-1095.1% |
Return on assets (ROA) |
-208.6%
|
-113.7%
|
-42.5% |
Current ratio |
78.9%
|
190.3%
|
631.9% |
Return on equity (ROE) |
-2096.9%
|
-217.2%
|
-50.2% |
Change turnover |
22,411
|
22,753
|
8,591 |
Change turnover % |
63%
|
176%
|
197% |
Chg. No. of employees |
6
|
5
|
-5 |
Chg. No. of employees % |
12%
|
11%
|
-10% |
Total value of public sale
Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.